PharmaTimes has a number of freely available RSS feeds – including one that covers all content on www.pharmatimes.com
- Johnson & Johnson reports phase 2 data showing nipocalimab reduced SLE disease activity
- European approval enables measles protection with CSL’s immunoglobulin Privigen
- JJP Biologics reports positive interim phase 1b data for nebaprubart
- Immunotherapy boost can spare more bladder cancer patients major surgery
- Deep Science Ventures and MDC partner to accelerate brain treatments
